Patents by Inventor Scott MIX

Scott MIX has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11866700
    Abstract: Aspects of the invention relate to antisense oligonucleotides directed to the interleukin 17 receptor (IL-17R), and other targets. Spherical nucleic acid formulations or compositions of antisense oligonucleotides and related methods of treatment are also provided.
    Type: Grant
    Filed: May 5, 2017
    Date of Patent: January 9, 2024
    Assignee: Exicure Operating Company
    Inventors: Richard Kang, Scott Mix, Ekambar Kandimalla
  • Publication number: 20200339989
    Abstract: Optimized inhibitory nucleic acids are provided. The nucleic acids have sequences which include an optimal inhibitory motif, such as GGG. Related methods are also described.
    Type: Application
    Filed: May 26, 2020
    Publication date: October 29, 2020
    Applicant: Exicure, Inc.
    Inventors: Weston Daniel, Scott Mix
  • Patent number: 10704043
    Abstract: Optimized inhibitory nucleic acids are provided. The nucleic acids have sequences which include an optimal inhibitory motif, such as a GGG. Related methods are also described.
    Type: Grant
    Filed: January 14, 2016
    Date of Patent: July 7, 2020
    Assignee: Exicure, Inc.
    Inventors: Weston Daniel, Scott Mix
  • Publication number: 20180327741
    Abstract: Optimized inhibitory nucleic acids are provided. The nucleic acids have sequences which include an optimal inhibitory motif, such as a GGG. Related methods are also described.
    Type: Application
    Filed: January 14, 2016
    Publication date: November 15, 2018
    Applicant: Exicure, Inc.
    Inventors: Weston DANIEL, Scott MIX
  • Patent number: 6279131
    Abstract: Programs which control conventional computerized test systems must be changed when a particular test instrument controlled by the system is changed to a different test instrument. In accord with this invention, the need for such program changes is minimized by utilizing a generic instrument interface for each class of test instruments. A separate specific instrument interface, which corresponds to the specific instrument to be utilized within the general class, is identified in accordance with global variables and a look-up table based upon the general instrument interface called for in the basic test program. A simulator interface is also provided to facilitate the debugging of a basic test program by generating simulated data responses as if an actual test instrument was connected.
    Type: Grant
    Filed: August 30, 1995
    Date of Patent: August 21, 2001
    Assignee: Lucent Technologies Inc.
    Inventors: Paula Marie Archambeau, James Michael Hajjar, Douglas Scott Mix